Technology & Science Advisory Board

In July 2023, CordenPharma established a new Technology & Science Advisory Board (TSAB) comprised of eight world-class experts from academia and industry, who will provide technological and scientific expertise to drive forward our continued growth and innovation. These selected advisors have been carefully chosen for their strategic guidance from various disciplines including chemistry, pharmacology, biotechnology, and regulatory affairs.

The formation of the TSAB was born out of CordenPharma's commitment to stay at the forefront of the pharmaceutical and biotechnology industries. The board members’ collective expertise will provide valuable insights into emerging trends, cutting-edge technologies, and regulatory advancements across all six CordenPharma technology platforms. By harnessing the knowledge and insights of these renowned scientists and industry leaders, we aim to enhance our capabilities in the efficient development and manufacturing of APIs, Lipid Excipients, Drug Products, and Integrated Supply to support the complex modalities and evolving needs of our customers and their life-saving medicines.

Technology & Science Advisory Board

Dr. José de Chastonay

Independent Consultant for
Strategic M&A and Business Development
(Portugal / Switzerland)

Prof. Dr. C. Oliver Kappe​

Professor of Chemistry,
University of Graz (Austria)

Prof. Dr. Hiroshi Kikuchi

DDS Strategy Firm (Japan)

Prof. Dr. Olivia Merkel​

Professor and Chair of Drug Delivery,
LMU Munich (Germany)

Prof. Dr. Jean-Christophe M. Monbaliu

Professor of Organic Chemistry,
Center for Integrated Technology and Organic Synthesis
University of Liège (Belgium)

Dr. Christoph Rosenbohm, MBA

Chief Technology Officer (CTO),
Aloop Therapeutics (Denmark)

Prof. Dr. Roderich D. Süssmuth

and Chair of Biological Chemistry,
Technical University Berlin (Germany)

Prof. Dr. Karl Wagner

Professor of Pharmaceutical
Technology and Biopharmacy,
University of Bonn (Germany)

Board Member CordenPharma Technology
Platform of Interest
TSAB Expertise
Dr. José de Chastonay Decades of peptide industry leadership experience with emphasis on corporate development, business integration as well as operational and commercial activities.
Prof. Dr. C. Oliver Kappe Recognized as one of the most experienced experts in the field of flow chemistry.
Prof. Dr. Hiroshi Kikuchi The leading lipid expert in Japan, connected to all important lipid experts in the world.
Prof. Dr. Olivia Merkel Highly recognized expert in drug delivery for RNA and treatment of lung diseases.
Prof. Dr. Jean-Christophe M. Monbaliu Highly recognized flow chemistry expert with a strong background in multistep flow processes (lab and pilot scales).
Dr. Christoph Rosenbohm, MBA Long-standing experience in the field of oligonucleotides.
Prof. Dr. Roderich D. Süssmuth Highly recognized expert of peptides and synthesis of natural products.
Prof. Dr. Karl Wagner Expert in solubility enhancement, OSD in general and predictive biopharmaceutical tools.